Skip to main content
. 2021 Aug 24;12:709994. doi: 10.3389/fimmu.2021.709994

Table 3.

Intermediate precision of PGDM1400/PGT121/VRC07-523-LS standard curve.

mAb Conc (μg/ml) Mean FI-Bkgd %CV (3 curves)
PGDM1400 0.1 28018.88 1.79
0.05 27914.25 2.13
0.025 26289.13 1.38
0.0125 23187.63 3.55
0.00625 15701.00 11.94
0.003125 9146.88 12.46
0.001563 5118.38 20.86
0.000781 2746.13 12.31
0.000391 1424.63 12.34
0.000195 726.00 10.88
0.000098 373.75 15.55
0.000049 180.13 26.74
0.000024 166.88 4.53
0.000012 103.63 18.23
PGT121 0.5 27042.75 3.67
0.25 27073.38 2.77
0.125 26298.25 3.13
0.0625 24228.63 1.99
0.03125 18661.75 4.51
0.015625 11092.50 3.39
0.007813 6351.63 8.40
0.003906 3392.25 7.07
0.001953 1719.13 8.48
0.000977 877.63 9.35
0.000488 398.75 15.16
0.000244 201.50 26.83
0.000122 160.00 13.07
0.000061 84.75 33.69
VRC07-523-LS 1 25855.00 5.03
0.333333 26093.88 3.75
0.111111 24698.63 5.46
0.037037 23454.38 8.45
0.012346 21074.75 11.35
0.004115 14348.63 11.35
0.001372 7102.88 11.24
0.000457 2736.75 13.58
0.000152 940.63 16.44
0.000051 341.63 28.22
0.000017 173.75 65.48
0.000006 50.75 173.37
0.000002 120.50 66.03
0.000001 48.38 157.62

The table shows the average binding (Mean FI-Bkgd) of each standard curve performed by the same operator over the time course of 40 days at each dilution as well as the %CV, which was less than 14% at each dilution within the linear range of the curves. Values in bold are above the LOD in FI-Bkgd for the respective mAb and curve.